Sight threatening immune responses that damage the eye characterize intraocular inflammatory diseases. These diseases including uveitis and age-related macular degeneration are worryingly common and quality of life shattering. Genetic studies in past decades significantly advanced our understanding of the etiology of these devastating diseases. Unfortunately, patient genetics alone failed to adequately explain disease origin, susceptibility, and progression. Non-genetic factors such as the epigenetic regulation of ocular diseases and the environmental factors triggering intraocular inflammation offer new insight into intraocular inflammatory disorders. Importantly, mounting evidence is signaling that dysbiosis of human microbiota leads to rapid epigenomic reprograming of host cells and results in the onset of many diseases. In this review, we discuss how epigenetic mechanisms and microbiota may cooperate to initiate and perpetuate ocular inflammation. Lastly, we propose that the discovery of intraocular microbiota presents a significant shift in thought affecting current approaches to the diagnosis, treatment, and prevention of intraocular inflammatory diseases such as uveitis and age-related macular degeneration. The geographical and genetic background difference in both disease presentation and genetic association of intraocular inflammatory diseases may be due to the variation of intraocular microbiota.
Epigenetics

What is epigenetics?
In the course of biological study, many researchers found numerous biological phenomena could not be explained by genetic principles alone. Conrad Waddington (1905 Waddington ( -1975 proposed the word "epigenetics" phenomena in 1942 (Waddington, 1942) . The prefix "epi" of Greek origin means "over, outside of, or around". Therefore, the epigenetics refers to the study of phenomena "in addition to" genetics (Waddington, 1968) . Examples of epigenetics include DNA methylation, post-translational protein modification of histones around which DNA is wrapped, and large scale differences in genome structure. Epigenetic functions are of fundamental importance during literally all biological processes (Goldberg et al., 2007) , and an explosion of research efforts in past decades explored these important non-genetic functions.
The concept of epigenetics has evolved gradually from a general definition to a category of molecular mechanisms controlling the "in addition to genetic" phenomena. It was first defined broadly as "the branch of biology which studies the causal interactions between genes and their products, which bring the phenotype into being" (Waddington, 1942) . Later, Holliday defined epigenetics as "the study of the mechanisms of temporal and spatial control of gene activity during the development of complex organisms" (Holliday, 1990) , Russo et al. defined epigenetics as "the study of mitotically and/or meiotically heritable changes in gene function that cannot be explained by changes in DNA sequence" (Russo and Riggs, 1996) . Bird defined epigenetics as "the structural adaptation of chromosomal regions so as to register, signal or perpetuate altered activity states" (Bird, 2007) . Broadly, epigenetics bridges gaps between genotype and phenotype and provides a conceptual explanation for why the same genotype can result in various stable and heritable phenotypes (Wu and Morris, 2001 ). In particular, epigenetics constitutes the molecular events controlling gene expression and activity without changes of DNA sequence. These molecular events include covalent and noncovalent modifications of DNA and histones that shape/reshape the chromatin structure according to environmental cues (Allis and Reinberg, 2006) . Therefore, the study of chemical reactions shaping chromatin accessibility, regulating output of genetic information in terms of expression, and the signals from the environment that coordinate these chemical reactions represents the fundamental aspects of epigenetic research.
Genetics and epigenetics in higher organisms can be simply understood using a analogy with a modern computer. Thinking of a single cell as a computer system, the genome represents the "hardware" while the epigenome can be viewed as the "operating system" of our computer. The signaling cascades transferring information between outside and inside of cells can be viewed as "software" (Fig. 1) . Nowadays it becomes much easier to change the hardware of a computer. Similarly CRISPR-cas9 systems are making genome editing fast and efficient. However, the interdependent nature of software and hardware make it necessary to build a good operating system and run diverse software in order to take full advantage of the hardware. We will continue to discuss in this review the interdependency of genetic and epigenetic factors as they relate to eye health.
Why epigenetics?
In general, all physiology and pathology of living organisms are controlled by either genetic or epigenetic mechanisms. Originally genetic mutations were thought to be the sole source of phenotypic variations; however, the many examples of heritable phenotypes resulting from identical DNA sequence forced researchers to look to epigenetics for an adequate theory (Dupont et al., 2009 ). For example, most cells in complex organisms share an identical genome but feature diverse morphology and function. A naïve CD4 + T cell is activated upon antigen stimulation, differentiates into Th1, Th2, or Th17 cells, and acquires helper T cell functions, without genotypic modifications (O'Shea and Paul, 2010; Wei et al., 2009) . A fully committed somatic cell can be converted back to an induced pluripotent stem cell (iPSC) (Takahashi and Yamanaka, 2006) or transdifferentiated into another cell type by introducing certain key factors or by stimulation of small molecules without changing the cell's genome (Xie et al., 2017) . Therefore, it is crucial to appreciate that cellular phenotype and function are not solely decided by genetic information. Instead, they can be regulated by signals generated in the gene's environment through epigenetic mechanisms.
Inherited genetic materials were once blamed for causing most of human diseases before the human genome was sequenced. However, recent studies have revealed that dysfunction in epigenetic regulation underlies the mechanisms of many common and complex human diseases such as cancer (Ashford et al., 2015; Feinberg, 2007; Tomasetti et al., 2017) . In the past two decades, twin studies have been used to dissect the causal contribution from heritable versus environmental factors in the pathogenesis of complex phenotypical traits and diseases including those in the eye (Montezuma et al., 2007; Sanfilippo et al., 2010; Tan et al., 2015) . We summarized the heritability of eye diseases identified by large twin studies in Table 1 . The heritability of various eye diseases such as myopia and hyperopia, measured by the concordant rate between identical twin pairs, is as high as 90% (Hammond et al., 2001b) . In contrast, the heritability of other ocular diseases such as AMD is relatively low (37%) (Hammond et al., 2002) . Other than a few cases, no reports have been made on the concordant rate of uveitis between identical twin pairs. Other factors such as lifestyle, stress, nutrition/diet, and behaviors such as smoking can all change the risk of disease onset (Sobrin and Seddon, 2014) . These reports argue that nongenetic factors, often referred to as environmental factors, play a crucial role in the pathogenesis of most eye diseases.
What to study in epigenetics?
Environmental factors including protein and chemical molecules rarely function by modifying DNA sequences. In most cases, they directly or indirectly interact with and adjust the epigenome to alter gene expression. Therefore, the search for environmental mechanisms of disease focus on the epigenetic changes of chromatin structure, DNA methylation status, histone modifications, or non-coding RNAs that modulate gene expression regulation resulting from environmental cues (Fig. 2) . DNA methylation at the 5' cytosine is a predominant form of DNA methylation found in eukaryotes and generally contributes to gene silencing (Suzuki and Bird, 2008) . Its prevalence in eukaryotic genomes Fig. 1 . The cell as a computer: An analogy for genetics and epigenetics. Imagine the cell as a computer. The genome represents the unchanging but fundamental hardware, and the epigenome represents the operating system. The epigenome makes use of the underlying hardware (genome). to execute software programs (regulatory programs) that will interact with the outside work (the signaling cascade), create outputs (secreted proteins), and even reprogram the operating system (epigenetic reprogramming).
varies significantly, ranging from virtually no genes in yeast and 4% in Mus musculus to as high as 14% in Arabidopsis thaliana (Capuano et al., 2014) . However, in many clusters of CG dinucleotides, most cytosines (70-80%) can be methylated, called CpG island hypermethylation. Despite their association with gene siliencing, these methylated CpG islands can appear in gene promoters or gene bodies of actively transcribed genes. Beyond CpG islands, many studies indicate the localization of tissue-specific or tumor-specific DNA methylation in the CpG island "shores" (2 kb regions out from CpG islands) (Doi et al., 2009; Irizarry et al., 2009 ) and/or CpG "shelves" (2 kb regions out from CpG shores) (Fazila Asmar and Grønbaek, 2015) . Although DNA demethylation generally marks transcriptional activation in both plant and mammalian genomes (Laird, 2010) , recent studies support context dependent transcriptional regulation by DNA methylation or demethylation (He et al., 2013) .
DNA methyltransferase (DNMT) family proteins are responsible for the maintenance and de novo establishment of DNA methylation genome-wide. DNMT1 maintains heritable DNA methylation patterns through cell cycles, while DNMT3a/3 b and their cofactor DNMT3L establish de novo DNA methylation patterns during cell differentiation (Deaton and Bird, 2011; Law and Jacobsen, 2010) . In recent years, progress has been made in uncovering the molecular mechanism underlying DNA demethylation (Wu and Zhang, 2017) . In mammalian cells, it has been found that the ten-eleven translocation proteins (TET1, TET2, TET3), a family of iron-dependent oxygenases, mediates a process that combines deamination and oxidation of 5-methyl-cytosine to form 5-hydroxymethyl-cytosine (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009) , 5-formylcytosine, and 5-carboxylcytosine Ito et al., 2011) , sequentially removing 5-methyl-cytosine from DNA (Nabel and Kohli, 2011) . Importantly, the crucial roles of TET family proteins, especially TET2, have been implicated in regulating T cell function (Ichiyama et al., 2015) and IL-6 mediated innate immunity .
In addition to DNA methylation, a catalog of post-translational covalent modifications of histones (> 18 types at > 60 amino acid residues on histones) is found to coordinate the epigenetic regulation of gene expression and cellular processes (Jenuwein and Allis, 2001) . Multiple post-translational modifications have all been found to regulate cell type specific epigenomic patterns. Some of the most well known modifications include the variations of lysine methylation (including mono-, di-, and tri-methylation), lysine acetylation, lysine ubiquitination, lysine sumoylation, lysine propionylation, lysine butyrylation, lysine formylation, arginine methylation, arginine citrulination, serine/threonine/tyrosine phosphorylation, proline isomerization, ADP ribosylation, serine O-GlcNAcylation, tyrosine hydroxylation, lysine 2-hydroxyisobutyrylation, and lysine crotonylation (Dai et al., 2014; Ruthenburg et al., 2007; Sakabe et al., 2010; Tan et al., 2011) . Although the functions of many histone modifications are yet to be fully defined, the marks associated with transcription activation such as H3K4me3, H3K14Ac, H3K9Ac, H3K27Ac, and H3K36me3, as well as repressive marks H3K27me3 and H3K9me3 have been extensively mapped in detail across many genomes and in various disease conditions . Many enzymes responsible for covalently modifying histones (named writers and erasers of epigenetic modifications) such as histone acetyltransferases (HAT) and deacetylase (HDACs), as well as histone methyltransferases and demethylases, have been extensively studied (Hyun et al., 2017) . In addition, proteins associated with modified histones have been named the readers, whose function depends on the interaction between the protein and epigenome (Qureshi and Mehler, 2014) . Among the readers of modified histones, proteins containing bromodomains (BRDs) such as BRD4, which specifically recognize ε-N-lysine acetylation motifs on histones, have been recognized as important regulators of gene transcription and drug targets for cancer therapy (Marmorstein and Zhou, 2014) .
The vast majority of mammalian genomic DNA and transcribed RNA does not coded for proteins. As scientists began to reject the "junk DNA" view of the non-coding genome, the discovery of functional non-coding RNA opened another chapter in our understanding of complex genomes. Short interfering RNA (siRNA), microRNA, piwi-interacting RNA (piRNA), small nucleolar RNAs (snoRNA), small nuclear RNA (snRNA), extracellular RNA (exRNA), small Cajal body-specific RNA (scaRNA), long-non-coding RNA (lncRNA), and non-coding circular RNA are all transcripts that interact with the transcription machinery and optimize gene expression regulation. The exact molecular mechanisms dictating how these RNA species function are yet to be fully elucidated, but they have been identified as the biomarkers for many diseases (Elkon and Agami, 2017; Esteller, 2011) .
Both genetic and epigenetic information maintains the heritability of cellular behavior. However, epigenetic mechanisms underlie the dynamic regulation of postmitotic cell phenotypes by managing access to the genetic hardware. In response to extracellular and intracellular environmental stimulations, DNA methylation, histone modifications, and non-coding RNA regulation collectively and interdependently decide the outcome of transcriptional regulation by either activating or repressing gene expression. In turn, genes with built-in genetic variations program the cell to appropriately behave under either physiological or pathological conditions. It is important to note that epigenetic mechanisms rely on both environmental cues and genetic variations in modulating the transcriptional regulatory networks. Therefore, it is the genome, epigenome, and environment that cooperatively shape cellular function and behavior (Fig. 2 ).
How to study epigenetics?
To identify and quantify locus-specific DNA methylation and histone modifications, the following methods are broadly utilized: 1) restriction enzyme based differential cleavage of methylated DNA; 2) sodium bisulfite conversion followed by routine sequencing or pyrosequencing; 3) DNA affinity capture using methyl DNA specific antibody or methyl-CpG binding domain (MBD) proteins; 4) chromatin immunoprecipitation using anti-modified histone antibodies, followed by locus-specific PCR detection of histone modifications (Laird, 2010; Rhee and Pugh, 2011) .
In the past decade, high-throughput sequencing technology has (Lim et al., 2015) revolutionized our ability to survey the global epigenetic changes within a cell population (Soon et al., 2013 ) and at the single cell level (Baslan and Hicks, 2014; Shapiro et al., 2013; Stelzer et al., 2015; Wen and Tang, 2017) . Chromatin immunoprecipitation coupled with highthroughput sequencing (ChIP-seq) constitutes the principle assay with which the genome-wide patterns of histone modifications are mapped (Barski et al., 2007) . Methylated/demethylated DNA immunoprecipitation coupled with sequencing ((d)MeDIP-seq), methylCpG binding domain immunoprecipitation coupled with sequencing (MBD-seq), and bisulfite sequencing provide the experimental tools for DNA methylation and demethylation profiling studies (Zuo et al., 2009) . Whole transcriptome sequencing (RNA-seq) allows researchers to monitor the expression of both coding and non-coding RNA . In addition, global chromatin accessibility can be surveyed using DNase I digestion followed by sequencing (DNase-seq) (Goldstein and Hager, 2017) and the assay for transposase-accessible chromatin sequencing (ATAC-seq) (Buenrostro et al., 2013; Corces et al., 2017; Schep et al., 2017) . In recent years, developments in DNA barcoding and microfluidic technologies have enabled the application of the above assays to single individual cells leading to unprecedented resolution of epigenetic states. The dramatic drop in high-throughput sequencing costs and significant improvement in assay sensitivity in past years have brought the fine-mapping of epigenetic changes at the single cell level into reality (Guo et al., 2017; Stelzer et al., 2015; Zhou et al., 2016) . Moreover, large consortium efforts such as NIH Roadmap Epigenomics Mapping Consortium (USA) (Bernstein et al., 2010) , The Human Epigenome Project (Europe) (Bradbury, 2003) , The International Human Epigenome Consortium (Bae, 2013) , and The ENCODE (Encyclopedia of DNA Elements) Consortium (ENCODE., 2004) have released a tremendous amount of data on the epigenomes in various cell types and disease conditions. Therefore, the enrichment of tool sets in epigenetic studies will certainly help to advance our understanding of biological process and disease pathogenesis.
Epigenetics of intraocular inflammatory diseases
Since epigenetic mechanisms act as an interface between genetics and the environment affecting phenotype changes in disease conditions, it is reasonable to expect that disease-specific alterations in DNA methylation, histone modifications, and non-coding RNA expression patterns contribute to ocular diseases where few genetic factors exist. Currently, only limited studies have reported epigenetic changes in ocular diseases. Examples include age-related macular degeneration (AMD), diabetic retinopathy, cataract, pterygium, retinoblastoma, uveal melanoma, glaucoma, keratitis, and uveitis (reviewed in (Gauthier and Liu, 2017; Gemenetzi and Lotery, 2014; He et al., 2013; Fig. 2 . The interdependency of environment, epigenome, and genome. The Gene X will not be switched on or off without an intracellular or extracellular signal. Changes in Gene X expression must associate with an alteration of the chromatin structure around Gene X loci. These changes depend on the epigenomic programs consisting of DNA methylation, histone modification, or non-coding RNA changes. On one hand, the protein encoded by Gene X will define/redefine the intracellular or extracellular microenvironment and cellular functions. On the other hand, both the product of Gene X (the protein) and an extracellular stimulus (microbiota or their metabolites) can trigger a stimulus-specific signaling cascade that leads to epigenomic reprograming, gene expression modifications, and cellular functional shift. SCFA: short chain fatty acid. Li et al., 2016; Liu et al., 2013; Pennington and DeAngelis, 2015; Sharma et al., 2017; Singh et al., 2016; Sobrin and Seddon, 2014; Zhang et al., 2017) . This review will only focus on those studies related to intraocular inflammation.
Behcet's disease (BD) is a multi-organ inflammatory condition affecting the eye, skin, and central neural system. Its pathology is characterized by mucocutaneous lesions, vasculitis, and uveitis (Davatchi et al., 2017) . Although polymorphisms in the human leukocyte antigen (HLA)-A (HLAA26) and HLA-B gene regions (HLAB51, HLAB15, HLAB57, and HLAB27) show significant association with BD, these genetic factors alone fail to explain the varied severity of BD . In a recent report, researchers profiled DNA methylation in patients with BD as compared to age-, sex-, and ethnicity-matched healthy controls (Hughes et al., 2014) . Genome-wide DNA methylation arrays detected 383 and 125 differentially methylated sites in the monocytes and CD4 + T cells respectively. These BD specific DNA methylation patterns were reversed by treatment. These results suggest that epigenetic regulation in monocytes and CD4 + T cells may be crucial in BD and the geographical differences in gene associations may result from different environmental conditions (Hughes et al., 2014) . Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly worldwide (Ardeljan and Chan, 2013) . Development of soft drusen between Bruch's membrane and retinal pigment epithelium (RPE) and loss of RPE cells in the macular region ultimately lead to irreversible vision loss (Khan et al., 2016) . The identification of strong genetic associations of complement factor H (CFH) and ARMS2-HTRA1 with AMD leads researchers to consider AMD as a genetic disease (McHarg et al., 2015) . Hunter et al. has found promoter hypermethylation and decreased expression of the Glutathione S-transferase isoforms mu 1 (GSTM1) and GSTM5 genes in AMD patients (Hunter et al., 2012) . Our epigenetic study has identified that hypomethylation of the IL17RC gene promoter and elevated expression of IL-17RC protein in diseased retinal tissue strongly associates with AMD risk (Wei et al., 2012) . However, Oliver et al. reported that the hypomethylation of IL17RC promoter was not found in their AMD cohort (Oliver et al., 2013) . Studies have shown that the DNA integrity decided by tissue processing procedures significantly affects detectable levels of DNA methylation (Rhein et al., 2015) . A standardized sample handling protocol shared by the research community might be needed to ensure the compatibility of DNA methylation detection assays. In addition, similar to geographic differences found in genetic studies (Cho et al., 2009; Edwards et al., 2008; Morton et al., 2016; Yang et al., 2008) , environment-dependent epigenetic changes may also characterize diseases such as AMD.
Microbiota
Genetic polymorphisms may alter protein function, and epigenetic modifications coordinate gene transcription regulation. Environmental cues inside and outside of the cell interact with both genome and epigenome to dynamically shape the cellular functional output. Environmental triggers make lasting changes to the cell when extracellular signals are transmitted through cytoplasmic signalizing cascades or to receptors that translocate to the nucleus, and lead to epigenetic reprogramming (Fig. 2) . The extracellular microenvironment is where information between cells is communicated. Therefore, it is important to consider what factors in the extracellular microenvironment trigger the epigenetic changes that lead to altered cellular function. The environmental triggers of inflammation that lead to epigenetic changes found in intraocular inflammatory diseases such as uveitis and AMD remain poorly understood. The emerging role of commensal microbiota may serve as triggers of immune responses and offer clues to the environmental origin of ocular inflammation.
The dilemma of pathogenesis of non-infectious uveitis: autoimmunity versus antimicrobial immunity
The eye is considered an immune privileged site (Streilein, 2003) with educational gates (Shechter et al., 2013) and the intraocular cavity is considered sterile unless it is invaded by pathogens. However, it remains unknown what triggers the onset and relapses of intraocular inflammation in non-infectious uveitis in which a causative infectious organism cannot be identified by microbiology culture or PCR assays. Despite much debate between competing theories of infection and autoimmunity, so called non-infectious uveitis remains unexplained (Forrester et al., 2013) .
The primary support for the autoimmune theory of non-infectious uveitis is derived from murine models of experimental uveitis (Caspi, 2010) . However, these murine models fail to fully phenotypically copy human non-infectious uveitis (Forrester et al., 2013) . Fundamental differences in genetics, living environment, food intake, and resident microbiota (Xiao et al., 2015) cast doubt on the possibility of murine models of uveitis recapitulating relevant features of the human disease.
Recent seminal studies in the experimental uveitis model have demonstrated a pivotal role for gut microbiota in inducing the autoreactive T cells and intraocular inflammation (Horai et al., 2015; Nakamura et al., 2016) . These reports have proposed an important hypothesis that the activation of pathogenic auto-reactive T helper cells is triggered by the unidentified gut microbial species. The systemic administration of combinatory antibiotics as well as germ-free environment can both lead to the deletion of most or all bacterial species in all host organs including the eye. Therefore these data do not preclude the possible role an intraocular microbiota plays during the onset of uveitis. Moreover, it is still illusive how these activated T cells could enter the eye without an instructive infiltration signal from a quiet intraocular environment. Supposing the immune memory of these selfreactive T cells is maintained, the ocular infiltration is a random event, and the host antigens targeted by T cells will never be fully removed, one would expect that uveitis is an inflammatory disease that persists indefinitely. This is not true in the case of human uveitis. Importantly, the murine models of uveitis all require a co-administration of bacterial products as the adjuvant (Caspi et al., 2008) , while the absence of host antigen IRBP can lead to better induction of the disease (Avichezer et al., 2003) . These results all emphasize the essential role of microbes (probably from the gut) instead of autoantigens in triggering the pathological immune responses that damage the eye in the murine models of uveitis.
Autoantibodies against ocular antigens serve as the main evidence for the autoimmune etiology of non-infectious uveitis in clinical studies. Puzzlingly, those autoantibodies are not uniquely detected in uveitis patients and are rather part of the "natural" autoantibody repertoire (Forrester et al., 1989) . The retinal antigens in human that trigger the "auto"-immune responses in non-infectious uveitis remain an enigma. Candidate antigens, including S-arrestin (human protein SAG or S-antigen), neither localize exclusively in the eye nor satisfactorily explain the unilateral nature and the extremely diverged clinical presentations of various types of uveitis (Forrester et al., 2013) .
Interestingly, our study identified a personalized microbiome inside of uninflamed human and animal eyes (manuscript submitted) as well as in the eyes from a patient with uveitis (Fig. 3) , using high-throughput metagenomic and metatranscriptomic sequencing technologies. These findings could potentially explain certain phenomena present during the process of intraocular inflammation. The intraocular microbiota may be inaccessible, invisible, or tolerated by the human immune system. Ocular cells may process and present foreign peptides through MHC class I molecules on their surface without immediately inducing a functional immune response. Once a breakdown of the tolerance and/or the physical barriers occurs, specialized immune responses against the pathogenic microbes initiate and target the ocular cells presenting the foreign antigens on their surface.
Our analysis of the intraocular microbiome also suggests that the intraocular microbiota consists of non-sporadic species that associate with host genetics such as HLA-B27 and may predispose individuals to the risk of intraocular inflammation. When pathogenic microorganisms only appear inside the eye, breakdown of the immune tolerance to the pathogens or the blood-ocular barriers could lead to recruitment of inflammatory cells and intraocular inflammation potentially explaining unilateral uveitis without involvement of other organs (Local Inflammation in Fig. 4) . When multiple organs including the gastrointestinal track, skin, lung, and oral cavity share certain pathogens, T cell dependent immune responses against the shared pathogen may mediate systematic immune syndromes such as Behcet's disease and sarcoidosis (Systemic Inflammation in Fig. 4 ). Our proposed model could also explain why certain forms of uveitis are resistant to immunosuppressive therapy alone without clearance of the trigger antigens.
It is well documented that prior infection history (Szanto et al., 1991) or poor oral hygiene (Galeone et al., 2012) has been associated with the development of acute anterior uveitis or Behcet's disease supporting the model of systemic infections as the potential trigger of human non-infectious uveitis. New evidence that autoimmune disorders may ultimately have a pathogenic origin in other diseases has emerged (Vatanen et al., 2016) , raising questions about the elusive origins of "auto"-immune diseases. Therefore, it is a plausible hypothesis that the intraocular microorganisms serve as either adjuvants or direct antigens presented on host cells that trigger pathological intraocular inflammation.
Intraocular microbiota and AMD
The existence of intraocular microbiota opens a Pandora's Box of microorganism-related etiology for all ocular manifestations. The composition, function, and dynamic regulation of intraocular microbial communities may affect many diseases such as AMD.
The past decade witnessed an explosion of research focusing AMD. Many previous works have extensively reviewed the current understanding of the pathology and pathogenesis of AMD (Jager et al., 2008; Kersten et al., 2017; Nussenblatt et al., 2014) . A clear geographical and racial difference in both disease presentation and genetic association has been found in AMD patients around the world (Sommer et al., 1991; Wong et al., 2016) . For example, the majority of Caucasian AMD patients suffer the dry form of AMD (geographic atrophy), while Asian AMD patients are more likely to suffer wet AMD or polypoidal choroidal vasculopathy (PCV). The strongest genetic risk factor of AMD in Fig. 3 . A microbiome found in the aqueous humor of a uveitis patient. A 10-year-old male, without history of any trauma or surgery, complained of sudden blurred vision in one eye and headaches for a month and was diagnosed as unilateral pan-uveitis in July 2011 in the clinics of Zhongshan Ophthalmic Center. The metagenomic and metatranscriptomic analysis of the aqueous humor from his eye with inflammation identified a microbiota that consisted of numerous bacteria in his AH specimen. Multiple strains of gram positive bacterium Propionibacterium acnes were found, which accounted for over 70% of total bacterial abundance of DNA. Other bacterial species such as Acidovorax ebreus and Pseudomonas fluorescens only accounted for a minority of the community (< 10%).
Caucasians, CFH Y402H, is not associated with Asian AMD. Similarly, genetic polymorphism in the HTRA1 gene only associates with Asian PCV but not Caucasian AMD (Wong et al., 2016) . This difference points to possible environmental factors, other than the combination of multiple genetic factors, which may differentially affect the initiation of AMD.
The early pathological manifestation of AMD, drusen, exhibits various appearance including hard drusen, soft drusen, cuticular drusen, reticular pseudodrusen, and ghost drusen (Khan et al., 2016) . Many of these drusens come and go while only the soft drusen has been associated with AMD risk (Wang et al., 2003) . It is well studied that the drusen consist of complement components, apolipoprotein E, amyloid Aβ proteins, vitronectin, immunoglobulins, and C1Q (Crabb et al., 2002; Johnson et al., 2002; Khan et al., 2016; Yoshida et al., 2005) , all of which were recently designated as anti-infectious agents (Kattan et al., 2008; Kumar et al., 2016; McHarg et al., 2015; Singh et al., 2010) . In addition, drusen components have been shown to induce NLRP3 (nucleotide-binding domain, leucine-rich repeat-containing family, and pyrin domain-containing 3) mediated inflamasome activation (Doyle et al., 2012; Gnanaguru et al., 2016; Tseng et al., 2013; Wang et al., 2016) and release of IL-1β and IL-18 in retinal tissues (Doyle et al., 2012) . Since IL-18 may not function to stop the pathology of AMD (Doyle et al., 2014 (Doyle et al., , 2015 Hirano et al., 2014; Ijima et al., 2014) , it may be only needed during the early phase of AMD. The anti-infectious agents in drusen and their activation of NLRP3-mediated inflamasomes offer evidence of a possible infectious etiology for drusen formation as part of a programmed response to ocular infection.
The discovery of intraocular microbiota in AMD patients provides more evidence supporting the infectious etiology of AMD. We found that the bacterium Bacillus megaterium was significantly enriched in soft drusens from AMD patients (manuscript submitted), and when inoculated subretinally in a non-human primate model, Bacillus megaterium induced drusen-like pathology (Fig. 5) . The possibility that other bacteria or microorganisms could play the same key role in the formation of drusen could explain the varying shape and size of drusen observed across AMD patients. Importantly, it is reasonable to speculate that the antimicrobial responses in drusens can be significantly affected by those genetic defects in genes such as CFH and HTRA1, both of which are suppressors of excessive immune responses (Ferreira et al., 2010; Friedrich et al., 2015) . Therefore, our findings that intraocular microbiota mediates the pathogenesis of AMD provide a new avenue for diagnosis, therapy, and prevention of this devastating disease.
Association of gut microbiota with ocular diseases
The host-microbial interaction has been redefined in the past two decades due to our ability to view the microbiome in a high-throughput way (especially using high-throughput DNA sequencing technology) (Foster et al., 2017) . The microbiome colonizing many human organs including GI track, skin, vagina, oral cavity, respiratory track, and normal ocular surface have been extensively studied, leading to the concept of the "holobiont" which emphasizes the integration of both host and microbial functions in controlling physiological and pathological conditions (Bordenstein and Theis, 2015) .
The gut holds the community with the most abundant microbes in the human body (Tropini et al., 2017) . The composition and function of the gut microbiota have been linked to many physiological functions such as innate and adaptive immunity (Honda and Littman, 2016; Thaiss et al., 2016) and pathological conditions such as obesity, diabetes, inflammatory bowel disease, cancer, depression, Parkinson's disease, and autism . Recently, Rachel Caspi's group has found the key role of gut microbiota (Horai et al., 2015) and ocular surface commensals (St Leger et al., 2017) in intraocular inflammation and ocular surface immunity, respectively. In addition, Nakamura et al. has also shown that modulating the gut microbiota changes the severity of inducible uveitis in mouse (Nakamura et al., 2016) . Intriguingly, as a preliminary study, Zinkernagel et al. has found the bacterial genera Anaerotruncus and Oscillibacter, as well as bacterial species Ruminococcus torques and Eubacterium ventriosum were enriched in the fecal samples from 12 AMD patients as compared to 11 healthy controls (Zinkernagel et al., 2017) . Andriessen et al. has suggested gut dysbiosis induced by high fat diets in mice exacerbate choroidal neovascularization (Andriessen et al., 2016) . Rowan et al. also demonstrates lower-glycemia diet and the cometabolites of gut microbiota serotonin can protect mice from AMD-like pathology (Rowan et al., 2017) . Taken together, the dysbiosis of gut microbiota and its metabolites may be crucial in inducing and promoting intraocular inflammation.
Control of intraocular inflammation
Intraocular inflammation can be triggered by the microorganisms inside of the eye. This initiation of immune responses must associate with changes of epigenomes in cells functioning for innate and adaptive immunity, leading to production of immune mediators (cytokines etc.), recruitment of immune cells to the inflammatory sites, and finally tissue damages and/or recovery. Therefore, several therapeutic strategies can be applied to control the intraocular inflammation (Fig. 6) .
Control of active intraocular inflammation, particularly uveitis, needs effective immunosuppressive therapy. Corticosteroid, antimetabolites, calcineurin inhibitors, as well as biologics are broadly used currently in treating uveitis (Jabs, 2017) . In AMD treatment, anti-VEGF antibodies are the major agents stopping the neovascularization and rescuing vison loss for wet AMD. Unfortunately, effective therapies for dry AMD have yet to be discovered (Abd et al., 2017) . The recent development of epigenetic drugs that target epigenetic machinery, including the writers, readers, and erasers of epigenetic modifications, provides an important new tool for immunosuppressive therapy (Ahmadi et al., 2017) . Among these drugs, histone deacetylase inhibitors (HDACi), histone methyltransferase inhibitors (HMTi), DNA methyltransferase inhibitors (DNMTi), and bromodomain extraterminal (BET) inhibitors have been approved by regulatory agencies and used for treatment of diseases such as cancer (Ramadoss and Mahadevan, 2017) . Importantly, several compounds, such as JQ1 (Cheung et al., 2017; Eskandarpour et al., 2017; Hammitzsch et al., 2015) , have shown promising immunosuppressive effects in clinical settings. These drugs show potential for controlling intraocular inflammation through systemic or local drug administration. The epigenetic drugs improve their specificity by targeting the cell type specific epigenetic regulatory networks as compared to those immunosuppressive agents that have a very broad spectrum of targets and significant complications. Moreover, they can control multiple cytokines and immune mediators instead of one cytokine per time as the antibody drug does, which further improves their effectiveness in controlling intraocular inflammation (Fig. 6) .
As the infectious etiology of AMD starts to be gradually recognized, how to target specific bacteria or microbiota for AMD therapy is still unclear. Local or systemic antibiotic treatment may help to kill the pathogenic bacteria. However, treating the dysbiosis of microbiota inside and outside of the eye may also lead to more problems rather than a cure due to the development of antibiotic resistance. Therefore, extra caution is needed for non-specific antibiotics therapy. Recent reports suggest that combination therapies of probiotics and prebiotics bears great potential for correcting the dysbiosis of microbiota in the gut and restoring the healthy mutualism of the holobiont (Markowiak and Slizewska, 2017) . More work is warranted to explore the possibility of targeting the triggers of ocular inflammation in AMD and uveitis. Fig. 5 . The fundus view of a monkey retina at Week 5 post subretinal injection of Bacillus megaterium. The subretinal bacterial infection was performed as following: the macaques were sedated by intramuscular injection of a mixture of tiletamine hydrochloride (2.5 mg/kg) and xolazepam hydrochloride (2.5 mg/kg), followed by pupil dilation with 0.5% tropicamide and 0.5% phenylephrine. A 35 gauge anterior chamber cannula was inserted through a sclerotomy and advanced through the vitreous. Under microscopic monitoring, 50 CFU bacterium in 50 μl of PBS was injected into the subretinal space between photo receptors and RPE, using a NanoFil Syringe Nanofil-100 for Microinjection (World Precision Instruments, USA). The fundus image was obtained on day 35 post injection.
Future directions
Our finding that microbiota live in the intraocular space raises key questions as to whether other tissues/body sites that are currently considered sterile under physiological conditions (such as the joint, cerebrospinal cord, and dermis) harbor their own commensal microbial communities. Such discoveries of resident microbial flora in these sites may offer an attractive new paradigm in the investigation of the notoriously elusive etiologies of organ-specific or multiple-organ-specific inflammatory diseases such as Behcet's disease that involve mucosal tissues, vasculature, skin, eye, and central neural system. The existence of intraocular pathogenic microorganisms does not exclude other possible mechanisms of intraocular inflammation. Alternative triggers for inflammation could include molecular mimicry, live microorganism translocation, or microbial metabolite translocation in the eye . As traditional approaches to autoimmune diseases have failed to identify their origins, we believe the theory of resident microorganisms deserves serious consideration.
Another important question of how commensal and pathogenic microbes gain entrance to the intraocular space is still unsolved. One hypothesis is that the temporary breach of blood ocular barrier leads to exchanges between serum microbiota and intraocular microbiota. Moreover, phagocyte mediated intracellular microorganism translocation serves as a promising possibility by which bacteria could gain entry into immune privileged sites.
Recent studies have demonstrated that both intestinal microbiota and their metabolites such as short-chain fatty acids (SCFAs) can regulate the key functions of immune cells and neuronal cells through directly or indirectly modifying the epigenome of various cell types (Thion et al., 2017; Woo and Alenghat, 2017) . The community's exploration of host-microbiota interaction through epigenetic modification has only just begin, and at this time it is unclear whether or how the intestinal and ocular local microbiota interact with resident cells in the eye. A fundamental research direction for the future will be determining the molecular mechanisms by which dysbiosis of intraocular microbiota may lead to epigenomic dysregulation and result in ocular inflammatory diseases such as AMD and uveitis.
New technologies have allowed unprecedented exploration of the microbial biodiversity on and in the human body. Many uncharacterized and highly divergent microbes are believed to constantly colonize and interact with human body (Kowarsky et al., 2017) . Characterization of the previously unknown or unappreciated epigenetic and microbial forces at work in human health will revolutionize our view of the etiology of ocular inflammation and fundamentally change the ways in which we understand and treat ocular inflammation in future.
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